India introduces locally developed H5N1 vaccine for chickens
Where it stands
India introduced a locally developed H5N1 bird-flu vaccine for chickens on 20 November. The Indian Council of Agricultural Research’s National Institute of High Security Animal Diseases developed it in Bhopal. The vaccine targets a particular genetic branch of the virus, called clade 2.3.2.1a. Bird-flu outbreaks can kill poultry and force authorities to destroy exposed flocks to contain infection. Farmers can lose birds, egg production and income together. A vaccine helps chickens develop an immune response before exposure. The government says the new vaccine is intended to strengthen protection against this virus branch and reduce poultry losses. Agriculture Minister Shivraj Singh Chouhan introduced the vaccine and quoted a cost of ₹1–2 per dose. The technical announcement identifies it as an inactivated vaccine, made using virus that has been killed. The announcements describe development and introduction. They give no date for nationwide farm distribution.
Background
Bird flu is influenza infection in birds. Some forms spread rapidly through poultry and cause severe disease. Infection can move between farms through infected birds and contaminated material, making an outbreak costly to contain. H5N1 is a subtype of influenza A virus. Viruses within that subtype continue to change, creating related genetic branches known as clades. Scientists identify the branch circulating in birds because differences between branches can affect how well a vaccine matches the virus. An inactivated vaccine exposes the immune system to killed virus. The bird can then develop a response that helps it recognise the infection. This approach adds vaccination to disease-control work such as monitoring outbreaks and limiting the movement of infected birds. India has recorded more than 500 H5N1 and H5N8 outbreaks together since 2006, according to the institute’s announcement. Repeated outbreaks have meant recurring losses from bird deaths, culling and trade restrictions. The new vaccine addresses that continuing poultry-health problem through a locally developed product.
How it developed
-
18 November 2026How it started
Researchers announce a vaccine matched to a virus branch
The Bhopal institute announced an inactivated H5N1 vaccine for chickens targeting clade 2.3.2.1a. It described the product as India’s first locally developed vaccine for this specific branch. The announcement scheduled its introduction for 20 November.
-
20 November 2026New fact
The vaccine is introduced in Bhopal
The agriculture minister introduced the vaccine at the institute and quoted ₹1–2 per dose. Local development gives India a product designed for the identified virus branch. The announcement does not specify when farms across the country will receive supplies.
Why it matters for UPSC
For GS3, explain how matching a vaccine to a circulating virus supports animal health and food security. Connect poultry-disease surveillance with farmers’ incomes, vaccine research and outbreak control.
Key terms
Sources (3)
- Press Information Bureau · official · ICAR-NIHSAD develops an inactivated H5N1 clade 2.3.2.1a vaccine for chickens21 Nov, 5:02 am
- Business Standard · India develops indigenous H5N1 vaccine for poultry21 Nov, 5:02 am
- Press Information Bureau · official · Locally developed H5N1 chicken vaccine dedicated in Bhopal, 20 November21 Nov, 5:02 am